Sterrett, R., Figueiredo, A., Mallick, R., Kekre, N., Atkins, H., & McCurdy, A. (2021). Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation – a retrospective analysis. Elsevier.
Cita Chicago Style (17a ed.)Sterrett, Russell, Amarilis Figueiredo, Ranjeeta Mallick, Natasha Kekre, Harold Atkins, y Arleigh McCurdy. Cyclophosphamide-glucocorticoids Versus Lenalidomide-dexamethasone as Treatment for Multiple Myeloma at First Relapse After Autologous Stem Cell Transplantation – a Retrospective Analysis. Elsevier, 2021.
Cita MLA (8a ed.)Sterrett, Russell, et al. Cyclophosphamide-glucocorticoids Versus Lenalidomide-dexamethasone as Treatment for Multiple Myeloma at First Relapse After Autologous Stem Cell Transplantation – a Retrospective Analysis. Elsevier, 2021.